The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness
Open accessAbstract
BACKGROUND: Constipation is a distressing side effect of opioid treatment. As a quaternary amine, methylnaltrexone, a mu-opioid-receptor antagonist, has restricted ability to cross the blood-brain barrier. We investigated the safety and efficacy of subcutaneous methylnaltrexone for treating opioid-induced constipation in patients with advanced illness. METHODS: A total of 133 patients who had received opioids for 2 or more weeks and who had received stable doses of opioids and laxatives for 3 or more days without relief of opioid-induced constipation were randomly assigned to receive subcutaneous methylnaltrexone (at a dose of 0.15 mg per kilogram of body weight) or placebo every other day for 2 weeks. Coprimary outcomes were laxation (defecation) within 4 hours after the first dose of the study drug and laxation within 4 hours after two or more of the first four doses. Patients who completed this phase were eligible to enter a 3-month, open-label extension trial. RESULTS: In the methylnaltrexone group, 48% of patients had laxation within 4 hours after the first study dose, as compared with 15% in the placebo group, and 52% had laxation without the use of a rescue laxative within 4 hours after two or more of the first four doses, as compared with 8% in the placebo group (P<0.001 for both comparisons). The response rate remained consistent throughout the extension trial. The median time to laxation was significantly shorter in the methylnaltrexone group than in the placebo group. Evidence of withdrawal mediated by central nervous system opioid receptors or changes in pain scores was not observed. Abdominal pain and flatulence were the most common adverse events. CONCLUSIONS: Subcutaneous methylnaltrexone rapidly induced laxation in patients with advanced illness and opioid-induced constipation. Treatment did not appear to affect central analgesia or precipitate opioid withdrawal. (Clinical Trials.gov number, NCT00402038 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foley, K. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130205 · Cited by 974
Yuan, C.-S., Foss, J. F., O'Connor, M., Osinski, J., Karrison, T., Moss, J., & Roizen, M. F. (2000) · JAMA · doi:10.1001/jama.283.3.367 · Cited by 297
Opioid-induced Delay in Gastric Emptying: A Peripheral Mechanism in Humans
Murphy, D. B., Sutton, J. A., Prescott, L. F., & Murphy, M. B. (1997) · Anesthesiology · doi:10.1097/00000542-199710000-00008 · Cited by 276
The use of quaternary narcotic antagonists in opiate research
Brown, D. R., & Goldberg, L. I. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90072-3 · Cited by 245
Opioids and the gut: pharmacology and current clinical experience
De Schepper, H. U., Cremonini, F., Park, M. ‐., & Camilleri, M. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00513.x · Cited by 214
Yuan, C.-S., Foss, J. F., O'Connor, M., Toledano, A., Roizen, M. F., & Moss, J. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90117-4 · Cited by 213
Treatment of opioid-induced constipation with oral naloxone: A pilot study
Culpepper-Morgan, J. A., Inturrisi, C. E., Portenoy, R. K., Foley, K., Houde, R. W., Marsh, F., & Kreek, M. J. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.106 · Cited by 208
Kolb, L., & Himmelsbach, C. K. (1938) · American Journal of Psychiatry · doi:10.1176/ajp.94.4.759 · Cited by 204
Low-Dose Oral Naloxone Reverses Opioid-Induced Constipation and Analgesia
Liu, M., & Wittbrodt, E. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00369-4 · Cited by 204
Sykes, N. (1996) · Palliative Medicine · doi:10.1177/026921639601000208 · Cited by 197
Cited by
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Chou, R., Ballantyne, J. C., Fanciullo, G. J., Fine, P. G., & Miaskowski, C. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.007 · Cited by 383
Opioid receptors in the gastrointestinal tract
Holzer, P. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.03.012 · Cited by 377
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
Corder, G., Tawfik, V. L., Wang, D., Sypek, E. I., Low, S. A., Dickinson, J. R., Sotoudeh, C., Clark, J. D., Barres, B. A., Bohlen, C. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4262 · Cited by 348
Swarm, R., Abernethy, A. P., Anghelescu, D. L., Benedetti, C., Blinderman, C. D., Boston, B., Cleeland, C., Coyle, N., deLeon-Casasola, O. A., Eilers, J. G., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0076 · Cited by 319
Self-citationLevy, M. H., Back, A., Benedetti, C., Billings, J. A., Block, S., Boston, B., Bruera, E., Dy, S., Eberle, C., Foley, K. M., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0031 · Cited by 303
Self-citationThe physiologic response and associated clinical benefits from provision of early enteral nutrition.
McClave, S. A., & Heyland, D. K. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609335176 · Cited by 279
Larkin, P. J., Cherny, N. I., La Carpia, D., Guglielmo, M., Ostgathe, C., Scotté, F., & Ripamonti, C. I. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy148 · Cited by 273
Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
Camilleri, M. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.30 · Cited by 262
Soergel, D. G., Subach, R. A., Burnham, N., Lark, M. W., James, I. E., Sadler, B. M., Skobieranda, F., Violin, J. D., & Webster, L. R. (2014) · Pain · doi:10.1016/j.pain.2014.06.011 · Cited by 262
NCCN Task Force Report: Management of Neuropathy in Cancer
Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., Junck, L., Morris, G. S., Paice, J. A., Tummala, S., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0078 · Cited by 257
An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome
Brandt, L. J., Chey, W. D., Foxx-Orenstein, A. E., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P. S., Spiegel, B. M., Talley, N. J., & Moayyedi, P. (2009) · American Journal of Gastroenterology · doi:10.14309/00000434-200901001-00002 · Cited by 225
Pharmacological treatment of chronic pain—The need for CHANGE
Varrassi, G., Müller-Schwefe, G., Pergolizzi, J., Orónska, A., Morlion, B., Mavrocordatos, P., Margarit, C., Mangas, C., Jaksch, W., Huygen, F., et al. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003689175 · Cited by 167
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction
Leppert, W. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s32684 · Cited by 72
Lee, M. C., Wanigasekera, V., & Tracey, I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.035 · Cited by 56
“…restricted mu-opioid-receptor antagonist, suggest that the effects within the central nervous system are important to pain relief afforded by systemic delivery of opioids in palliative care and chronic non-malignant pain (Anissian et al., 2012; Michna et al., 2011; Thomas et al., 2008).”
Metadata
- Authors
- Thomas, J., Karver, S., Cooney, G. A., Chamberlain, B. H., Watt, C. K., Slatkin, N. E., Stambler, N., Kremer, A. B., & Israel, R. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-29
- Volume
- 358
- Issue
- 22
- Pages
- 2332-2343
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2164341191
- Cited by
- 595
- References
- 18
- FWCI
- 65.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.